Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research note published on Tuesday morning. The firm issued a sell rating on the basic materials company’s stock.

Several other equities research analysts also recently issued reports on RKDA. Lake Street Capital upgraded shares of Arcadia Biosciences to a strong-buy rating in a research report on Tuesday, May 14th. HC Wainwright cut their price target on Arcadia Biosciences from $10.00 to $6.00 and set a buy rating for the company in a research note on Thursday, May 23rd.

Arcadia Biosciences Stock Down 0.7 %

Shares of RKDA stock opened at $3.00 on Tuesday. The firm has a 50 day moving average price of $2.79 and a two-hundred day moving average price of $2.62. The company has a market capitalization of $4.09 million, a PE ratio of -0.58 and a beta of 0.86. Arcadia Biosciences has a 12-month low of $1.85 and a 12-month high of $5.60.

Arcadia Biosciences (NASDAQ:RKDA) last issued its quarterly earnings data on Thursday, May 9th. The basic materials company reported ($1.78) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.52) by $0.74. The firm had revenue of $1.26 million during the quarter, compared to the consensus estimate of $1.20 million. Arcadia Biosciences had a negative net margin of 129.74% and a negative return on equity of 84.27%. During the same period last year, the business posted ($3.83) earnings per share. As a group, research analysts expect that Arcadia Biosciences will post -2.29 EPS for the current year.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.